?? EMA has started evaluating a marketing authorisation application for Bimervax, the #COVID19vaccine developed by HIPRA. Check out our latest updates on the #COVID19 pandemic: https://t.co/XbIRdjcT9T— EU Medicines Agency (@EMA_News) March 22, 2023
?? EMA has started evaluating a marketing authorisation application for Bimervax, the #COVID19vaccine developed by HIPRA. Check out our latest updates on the #COVID19 pandemic: https://t.co/XbIRdjcT9T